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Neurosteroids are cholesterol-based hormones that can be produced in the brain,
independent of secretion from peripheral endocrine glands, such as the gonads and
adrenals. A focus in our laboratory for over 25 years has been how production of the
pregnane neurosteroid, allopregnanolone, is regulated and the novel (i.e., non steroid
receptor) targets for steroid action for behavior. One endpoint of interest has been
lordosis, the mating posture of female rodents. Allopregnanolone is necessary and
sufficient for lordosis, and the brain circuitry underlying it, such as actions in the
midbrain ventral tegmental area (VTA), has been well-characterized. Published and recent
findings supporting a dynamic role of allopregnanolone are included in this review. First,
contributions of ovarian and adrenal sources of precursors of allopregnanolone, and the
requisite enzymatic actions for de novo production in the central nervous system will be
discussed. Second, how allopregnanolone produced in the brain has actions on behavioral
processes that are independent of binding to steroid receptors, but instead involve rapid
modulatory actions via neurotransmitter targets (e.g., γ-amino butyric acid-GABA, N-
methyl-D-aspartate- NMDA) will be reviewed. Third, a recent focus on characterizing the
role of a promiscuous nuclear receptor, pregnane xenobiotic receptor (PXR), involved in
cholesterol metabolism and expressed in the VTA, as a target for allopregnanolone and
how this relates to both actions and production of allopregnanolone will be addressed.
For example, allopregnanolone can bind PXR and knocking down expression of PXR in
the midbrain VTA attenuates actions of allopregnanolone via NMDA and/or GABAA for
lordosis. Our understanding of allopregnanolone’s actions in the VTA for lordosis has been
extended to reveal the role of allopregnanolone for broader, clinically-relevant questions,
such as neurodevelopmental processes, neuropsychiatric disorders, epilepsy, and aging.
Keywords: midbrain, ventral tegmental area, allopregnanolone, neurosteroid, reproduction, pregnane xenobiotic
receptor, non-genomic
INTRODUCTION
Now it is generally understood that cholesterol-based hormones
(“steroids”) can be produced in the brain and peripheral nerves
and not only in traditional steroid organs, such as the ovaries,
adrenals, and placenta. This notion is based on initial findings by
Baulieu and colleagues in the early eighties, and further supported
by decades of follow-up studies (Baulieu, 1980, 1991). These
steroids, which are produced in the brain and the peripheral
nerves, were given the name “neurosteroids” to differentiate
them from the same steroids that are produced by peripheral
glands. These initial discoveries demonstrated that precursors
to the pregnane steroids, such as pregnenolone were greater in
the brain and peripheral nerves, than in circulation. As well, the
same steroidogenic enzymes in the peripheral steroid gland were
found to be expressed in the nervous system and involved in
production of these molecules (Compagnone and Mellon, 2000;
Furukawa et al., 2002). These steroids measured in the brain
may be also products of metabolism of peripheral organ derived
precursors; these molecules are referred to as “neuroactive”
steroids. The pregnane steroid, 5α-pregnan-3α-ol-20-one (a.k.a.
allopregnanolone or 3α,5α-THP) will be the focus herein. Levels
of allopregnanolone in the nervous system can be much greater
than circulating levels, and even persist after removal of the
glands that produce pregnane steroids in the body (i.e., following
ovariectomy—OVX and/or adrenalectomy—ADX). Indeed, these
and other studies substantiated the notion that allopregnanolone
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is synthesized de novo in the brain and peripheral nerves, and
that levels in the nervous system are not only a product of
metabolism from peripheral gland-derived precursors and
subsequent accumulation in neural tissues (Baulieu, 1980, 1991;
Majewska, 1992; Paul and Purdy, 1992; Mellon, 1994). A central
question in our laboratory has been in determining the extent
to which allopregnanolone’s functional effects are related to its
synthesis in the brain, and/or metabolism of its precursors from
the periphery (e.g., progesterone), in the brain. A brief summary
of the key information supporting the role of allopregnanolone
as a neurosteroid and neuroactive steroid is as follows.
There are highly coordinated actions of steroidogenic enzymes
in neurons and glia in regions of the brain supporting production
of allopregnanolone as a neuroactive steroid and neurosteroid.
The brain and peripheral nerves express all of the enzymes
required for metabolism or biosynthesis of allopregnanolone
(Compagnone and Mellon, 2000). Regarding metabolism, cir-
culating progesterone, secreted from peripheral glands, can be
sequestered and accumulated in the brain, and then can be metab-
olized by enzymes to other neuroactive metabolites. Formation of
allopregnanolone from progesterone is dependent upon sequen-
tial actions of 5α-reductase (which produces dihydroproges-
terone), and then 3α-hydroxysteroid dehydrogenase (3α-HSD).
Additionally, allopregnanolone can be formed from biosynthesis
in the brain itself (Baulieu, 1991; Paul and Purdy, 1992; Mellon,
1994; King et al., 2002; Papadopoulos et al., 2006a,b; Batarseh and
Papadopoulos, 2010). The requisite factors for allopregnanolone
biosynthesis involves the 18kDA translocator protein (TSPO,
formerly known as the mitochondrial benzodiazepine receptor
or the peripheral-type benzodiazepine receptor), which binds
cholesterol at high affinity. TSPO, with the steroidogenic acute
regulatory (StAR) protein, have actions to transport cholesterol
into mitochondria, which is considered a rate-limiting step for
allopregnanolone biosynthesis (Mellon and Deschepper, 1993;
King et al., 2004; Papadopoulos et al., 2006a,b). Cholesterol is
then oxidized to pregnenolone by cytochrome P450-dependent
C27 side chain cleavage enzymes (P450scc), which is converted
to progesterone by 3β-hydroxysteroid dehydrogenase enzymes.
Progesterone from this biosynthesis, can then be converted to
allopregnanolone by actions of 5α-reductase and 3α-HSD. As
such, production of allopregnanolone can be from metabolism
of circulating progesterone, or de novo production of proges-
terone in the nervous system. All of these factors involved in
metabolism to, or biosynthesis of, allopregnanolone, described
above, are expressed in the spinal cord, cerebellum, hindbrain
(e.g., pons, medulla), midbrain (e.g., tegmentum), and forebrain
(e.g., corticolimbic regions, such as prefrontal cortex and hip-
pocampus, as well as basal ganglia, hypothalamus, and thalamus);
however, there are differences in expression based upon many
factors, including age, sex, hormonal milieu, cell type, context
(Mellon, 2007; Frye, 2009). Nevertheless, the vast distribution of
these factors, and their conservation across species (see review
Mellon, 2007), implies the importance of neuro(active) steroids,
such as allopregnanolone, for brain function, and supports inves-
tigations to understand the functional significance of allopreg-
nanolone from metabolism and/or biosynthesis (Melcangi et al.,
2014).
A focus in our laboratory for over 25 years has been how
production of allopregnanolone is regulated, and the novel tar-
gets for allopregnanolone’s functional effects, including behav-
ioral endpoints. This review will summarize early studies about
challenge/stressor-induced biosynthesis of allopregnanolone and
what is known about allopregnanolone synthesis and its actions
from studies using mating as a manipulation and measure in
our laboratory. Additionally, there will be a focus on recent
studies, and inclusion of data in support, regarding the role of the
pregnane xenobiotic receptor (PXR) as a novel factor for allopreg-
nanolone synthesis and actions. Lastly, there will be a discussion
of how these basic studies centered on allopregnanolone synthesis
and action in the midbrain of rodents have been extended to
clinically-relevant findings.
CHALLENGE-INDUCED ALLOPREGNANOLONE SYNTHESIS
Early studies investigating allopregnanolone as a neurosteroid
identified that environmental challenge, or stressors, can induce
allopregnanolone biosynthesis. In support, acute cold-water
swimming, an experimental model of an acute physical stressor in
rodents, increases brain production of allopregnanolone (Purdy
et al., 1991; Barbaccia et al., 1996; Vallée et al., 2000). Similar
effects are observed with other acute stressors, such as footshock,
ether exposure, and/or carbon dioxide exposure have been
demonstrated in intact, gonadectomized/ovariectomized (OVX),
and/or adrenalectomized (ADX) rodents (Paul and Purdy, 1992;
Barbaccia et al., 1996). Analogous effects in intact rodents and
those with peripheral sources of progesterone removed support
allopregnanolone biosynthesis as a response to these challenges.
Alternatively, allopregnanolone levels can be reduced following
exposure to chronic laboratory stressors in adult rodents, such
as social isolation (Serra et al., 2004; Agís-Balboa et al., 2007;
Pibiri et al., 2008; Nin et al., 2011; Pinna and Rasmusson, 2012).
Exposure to stressors of rodents in utero (e.g., immune challenges,
restraint stress, immune challenges, exposure to cold, swim stress
during the last week of gestation), or in early development
(e.g., maternal deprivation) produces long-lasting reductions in
allopregnanolone (Kellogg and Frye, 1999; Kehoe et al., 2000;
McCormick et al., 2002; Paris and Frye, 2011; Paris et al., 2011a,b).
There are functional effects of reducing allopregnanolone syn-
thesis related to these responses in that greater stress responding
is associated with lower levels of allopregnanolone (Zimmerberg
and Blaskey, 1998; Frye and Walf, 2004; Agís-Balboa et al., 2007;
Brunton and Russell, 2011; Paris et al., 2011a,b). Thus, it has been
recognized for some time that extreme situations and behavioral
experiences can alter allopregnanolone; however, there is now a
greater understanding of robust effects of ecologically-relevant
behavior, such as mating, on allopregnanolone synthesis.
MATING AS A MANIPULATION AND MEASURE FOR
INVESTIGATING ALLOPREGNANOLONE SYNTHESIS AND
ACTION IN THE BRAIN
To facilitate further understanding of allopregnanolone’s func-
tions and targets, and the role of its metabolism or biosynthe-
sis, it has proved useful to focus on a behavior that is reliant
upon allopregnanolone synthesis and actions (and subsequently
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FIGURE 1 | Depicts the midbrain allopregnanolone levels of behaviorally
tested animals compared to non-tested rats that were ovariectomized
(OVX) or OVX and adrenalectomized (OVX/ADX), estradiol-primed and
behaviorally tested in the paced mating task as a percent of the
non-tested controls. Rats in these conditions were also administered saline
vehicle or pregnane xenobiotic receptor (PXR) antisense
oligodeoxynucleotides (AS-ODNs) to the midbrain VTA. Paced mating
increased midbrain allopregnanolone levels of rats compared to what was
observed in the non-tested controls; this was attenuated with knockdown of
PXR.
extend this approach to other functions, described later in this
review). In our laboratory, mating behavior of female rodents is
thus utilized as both a manipulation and measure to elucidate
allopregnanolone’s role. From studies using this approach, the
importance of synthesis and actions of allopregnanolone in the
midbrain ventral tegmental area (VTA) have been consistently
revealed, and will be discussed in the following paragraphs.
MATING BEHAVIOR ASSESSMENT
The midbrain VTA is known for its actions for motivated
responses, and mating can be considered such a motivated behav-
ior. Mating responses of females are quantified with measures
of lordosis, proceptivity, and aggression. Lordosis, the necessary
posture of female rodents for mating, can be quantified in the
laboratory as the number of such responses by the female as
a ratio (or quotient; lordosis quotients) of the attempts by the
male. Other behaviors, such as proceptivity (courtship behav-
iors; proceptivity quotients) or aggression (rejection of males’
advances; aggression quotients) can be concurrently assessed with
lordosis. As well, in our laboratory, we typically assess other
behaviors beyond those directly related to mating, but those
that may have consequences for successful reproduction, such as
exploration, reductions in fear/anxiety, and social behavior with
conspecifics (for review see Frye, 2009). Mating is a motivated
behavior that is only observed under appropriate endocrine and
environmental contexts, and one in which the brain circuitry
necessary for it to occur (namely in the hypothalamus and
midbrain for female rodents), and may modify its expression
(e.g., corticolimbic structures), are becoming better characterized
(DeBold and Malsbury, 1989; Frye and Walf, 2008; Pfaff et al.,
2008; Frye, 2011).
ALLOPREGNANOLONE IN THE MIDBRAIN VTA IS NECESSARY AND
SUFFICIENT FOR MATING
By utilizing this behavioral response of mating as a bioassay, we
have been able to determine that allopregnanolone, from both
metabolism of circulating progesterone, and biosynthesis in the
midbrain, in the midbrain VTA is necessary and sufficient for
mating (reviewed recently in Frye, 2011). Requisite enzymes and
proteins for metabolism and biosynthesis of allopregnanolone
are expressed in the midbrain VTA as well as in corticolimbic
regions that may be involved (Cheng and Karavolas, 1975; Li
et al., 1997; Furukawa et al., 2002; Frye, 2011; Frye et al., 2013a).
Observations of age-related changes in reproductive behaviors
and timing of reproductive senescence among female rats suggest
that reductions in capacity to form allopregnanolone in the
midbrain may be involved (Walf et al., 2011). Genetic knockout
of 5α-reductase in female mice lowers allopregnanolone levels in
the midbrain and attenuates lordosis during proestrous (when
females typically have their highest levels of allopregnanolone,
coincident with mating), and following ovariectomy and
progesterone administration (Koonce and Frye, 2014).
5α-reductase knockout mice have normative responses to
allopregnanolone administration. In addition to these findings
that suggest the importance of progesterone metabolism in the
midbrain for mating, there are data in support of the role of
allopregnanolone synthesis in the VTA for mating. Antagonists of
TSPO, P450scc, and 3β-HSD, delivered directly to the midbrain
VTA, of receptive rats attenuates lordosis similarly as inhibitors of
metabolism by 5α-reductase and 3α-HSD (reviewed in Frye, 2011;
Frye et al., 2013a). As well, agonists of TSPO can have similar
actions as allopregnanolone to OVX and ADX rats to increase
midbrain levels of allopregnanolone and lordosis (reviewed
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FIGURE 2 | Depicts the midbrain allopregnanolone levels of paced mated
proestrous, ovariectomized (OVX) and estradiol-primed, or OVX and
adrenalectomized (OVX/ADX) estradiol-primed rats infused with saline
vehicle or pregnane xenobiotic receptor (PXR) antisense
oligodeoxynucleotides (AS-ODNs) to the midbrain VTA. Data are
represented as a percent of the saline-infused proestrous control group.
Administration of PXR AS-ODNs to the midbrain reduces allopregnanolone
levels in the midbrain following mating across these hormone conditions.
in Frye, 2011; Frye et al., 2013a). Together, these approaches
have suggested the importance of allopregnanolone, from both
metabolism and biosynthesis, in the midbrain VTA for mating.
MATING-INDUCED ALLOPREGNANOLONE SYNTHESIS IN THE
MIDBRAIN
In addition to being a measure of interest, mating can induce allo-
pregnanolone formation in the nervous system, and, thereby, can
be considered a manipulation as well. Among proestrous female
rats that engage in mating with a male, there is a rapid increase
in allopregnanolone levels in the midbrain; this same pattern of
allopregnanolone synthesis is not observed with the smell, or
site, of a sexually-experience male, or a female conspecific (Frye
and Bayon, 1999; Frye et al., 2007). Notably, allopregnanolone
levels are higher following “paced mating” compared to a stan-
dard mating task (Frye, 2001a,b, 2009, 2011; Frye et al., 2007,
2014b). Paced mating is considered a semi-naturalistic mating
paradigm as compared to a standard mating paradigm, which
is typically performed in a small chamber in a laboratory (e.g.,
a 10 gallon aquarium). Paced mating is considered closer to the
natural experience because the chamber is larger and divided with
an entry only a female can transverse to get to the other side
of the chamber; as such, female rats can control the timing of
(i.e., “pace”) their mating contacts with males, which is a critical
part of the natural response in the wild and to enhance fertility
and fecundity (Frye and Erskine, 1990). Even in the situation
that females are tested in a large, paced mating chamber in the
laboratory, but do not spontaneously pace, or show a low pacing
response (but the same number of mounts by the male), there
are lower levels of allopregnanolone in the midbrain compared
to females that do show the pacing response (Frye and Rhodes,
2006). These data support the notion that mating can induce
allopregnanolone synthesis; albeit, a question is the role of other
reproductively-relevant behaviors, which may precede or follow
mating, for allopregnanolone synthesis.
PACED MATING, MORE SO THAN OTHER REPRODUCTIVELY-RELEVANT
BEHAVIORS, INCREASES ALLOPREGNANOLONE SYNTHESIS
Reproductively-relevant behaviors are those that may
improve reproductive success. For example, some of these
reproductively-relevant behaviors are those that include increased
exploration and reduced anxiety that would promote females
leaving the natal nest and traversing a complex and novel
environment to encounter other female conspecifics and potential
mates for the first time. To address this in our laboratory, paced
mating as well as measures of exploration (e.g., open field),
anxiety (e.g., elevated plus maze), or social interaction with
another female are assessed in a short battery of these tasks.
Paced mating itself, or immediately following this battery of
tasks, increases allopregnanolone synthesis in the midbrain,
compared to testing in the battery without mating (Frye et al.,
2007, 2014b). Together, these data support that mating can be
utilized as a measure of allopregnanolone’s actions as well as
a way to manipulate allopregnanolone levels in the midbrain.
This model has then been used to assess the mechanisms of
allopregnanolone, with a focus on non-traditional actions for
mating and reproduction-relevant behaviors.
NON-TRADITIONAL ACTIONS OF ALLOPREGNANOLONE IN
THE MIDBRAIN VTA
Allopregnanolone has actions that are considered “non-
traditional” when compared to actions peripherally secreted
steroids have through binding to cognate steroid receptors in
their distal target organs, including brain regions involved
in reproductive and homeostatic processes, such as the
hypothalamus, midbrain, and limbic system (Pfaff et al., 1976;
Shughrue et al., 1997; Osterlund et al., 2000). These effects involve
dimerization of the steroid bound receptor, DNA binding, mRNA
transcription and translation, and, ultimately, protein expression
that would alter the behavior of the cell/organism (often referred
to as the “genomic” actions of steroids). It was believed that
the shortest latency of when hormones are secreted and bind
to receptors and initiate this intracellular process to ultimately
alter behavior was on the order of tens of minutes (and even
hours to days). This notion was challenged with the discovery
of neurosteroidogenesis, by which steroids could be produced in
the same tissue that they were having effects for behavior in, and
that steroids could have such effects so rapidly that they cannot
be explained by these genomic actions. To summarize decades
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FIGURE 3 | Depicts the lordosis quotients of proestrous (PRO),
ovariectomized (OVX) and estradiol-primed, or OVX and
adrenalectomized (OVX/ADX) estradiol-primed rats infused with
saline vehicle or pregnane xenobiotic receptor (PXR) antisense
oligodeoxynucleotides (AS-ODNs) and then a GABAA receptor
antagonist (bicuculline), or a NMDAR antagonist (MK-801) to the
midbrain VTA before behavioral testing. Data are represented as a
percent of the saline-infused proestrous control group. PXR AS-ODNs
to the VTA potentiated these effects of GABAA and NMDAR
manipulations.
of work by many laboratories, neuro(active)steroids, such as
allopregnanolone, are known to have rapid effects, including
those on neuronal excitability and synaptic function (Majewska
et al., 1986; Morrow et al., 1987; Gee et al., 1995; Brot et al.,
1997; Qiu and Lange, 2003; Weir et al., 2004; Lange, 2004; Belelli
and Lambert, 2005; Skildum et al., 2005). These rapid effects
are understood to involve direct or indirect modulation of ion-
gated or other metabotropic neurotransmitter receptors, rather
than traditional actions via cognate nuclear steroid hormone
receptors; these actions are referred to as a novel or non-
traditional actions of steroids. Indeed, many decades ago Hans
Selye reported rapid anesthetic and anti-convulsive properties of
allopregnanolone and other progestogens (Selye, 1941). In the
decades following these observations, GABAergic mechanisms
have been described for these anesthetic and anticonvulsant
effects of allopregnanolone as well as some of the anxiolytic
effects of allopregnanolone (Harrison and Simmonds, 1984;
Majewska et al., 1986; Belelli and Lambert, 2005). For over two
decades, our laboratory has been focused on GABA, dopamine,
and glutamate as targets of allopregnanolone in the midbrain
VTA for mating and reproductively-relevant responses.
ALLOPREGNANOLONE HAS ACTIONS VIA GABA, DOPAMINE, AND
GLUTAMATE FOR MATING
The VTA has rich innervation of dopamine targets and some of
allopregnanolone’s actions in the VTA for mating may involve
these targets, as well as GABA and glutamate. Progestogens can
increase release of GABA, dopamine and glutamate (Lévesque
and Di Paolo, 1990; Frye et al., 2000; Frye, 2001a,b). High levels
of progestogens enhance number, density, and affinity of GABAA
receptors, coincident with enhancing lordosis (Mascó et al., 1986;
Wilson, 1992; Frye and Vongher, 1999). There are D1 receptors
on dopaminergic cell bodies and GABAergic terminals as well
as NMDARs (Stoof and Kebabian, 1984; Bayer and Pickel, 1991;
Willick and Kokkinidis, 1995). Greater GABA input onto GABAA
receptors that are located on GABAergic interneurons in the
VTA mitigate inhibitory actions of these cells on dopamine cell
bodies, thereby increasing dopamine release (from cell body
and dendrites; Churchill et al., 1992). Excitation of D1 receptors
on GABAergic afferents in the VTA increases GABA release
(Kalivas and Duffy, 1995). Antagonists of D1 or GABAA reduce
allopregnanolone-facilitated lordosis when administered to the
VTA and the opposite pattern is observed with agonists of D1
or GABAA (Frye et al., 2004; Sumida et al., 2005; Frye and
Paris, 2009). Furthermore, antagonists of GABAA receptors to
the VTA reduce allopregnanolone-facilitated lordosis, and the
potentiation of this response by a D1 agonist co-administered
to the VTA (Frye et al., 2006c). A role of N-methyl-D-aspartate
receptor (NMDARs) is also suggested in this pathway. In support,
D1 expressing GABAergic terminals, synapse on dopaminergic
cell bodies that express both GABAA receptors and NMDARs
(Bayer and Pickel, 1991; Willick and Kokkinidis, 1995). Infusions
of a NMDAR antagonist to the VTA increases allopregnanolone-
facilitated reproductive responding of female rodents (Petralia
et al., 2007; Frye and Paris, 2011). Together these findings suggest
that allopregnanolone’s actions for reproductive responding in
the VTA may be related to reductions in tonic inhibition of
dopamine neurons in this region, involving actions of GABAA,
D1, and NMDARs here. Additional studies have suggested down-
stream pathways for these receptors, including, including activity
of G-proteins, adenylyl cyclase, phospholipase C and protein (a
discussion of which is beyond the scope of this review, but can
be found in Frye and Walf, 2008). Moreover, the functional role
of membrane targets of the progestogens, such as the membrane
progestin receptors, for reproductive indices have been shown
across aquatic species and terrestrial mammals (Tokumoto, 2012;
Tokumoto et al., 2012; Frye et al., 2013b, 2014c; Pang et al., 2013;
Petersen et al., 2013; Schumacher et al., 2014); the extent to which
there are interactions between these ionotropic and metabotropic
targets in the VTA is of continued interest. A microarray analysis
of gene expression changes in the midbrain of proestrous rats that
had been paced mated or not confirmed the role of the targets
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FIGURE 4 | Depicts the pattern of results for all behavioral measures
in the testing battery (open field, elevated plus maze, social
interaction and paced mating) of rats proestrous (PRO),
ovariectomized (OVX) and estradiol-primed, or OVX and
adrenalectomized (OVX/ADX) estradiol-primed rats infused with
saline vehicle or pregnane xenobiotic receptor (PXR) antisense
oligodeoxynucleotides (AS-ODNs) to the midbrain VTA. Data are
represented as a percent of the saline-infused control group for each
respective hormone condition. Pictures of the tasks are included about
the data bars. The most robust reduction in responding following PXR
AS-ODNs infusions to the VTA were observed in the social interaction and
paced mating task.
involved in allopregnanolone metabolism and biosynthesis, as
well as these neurotransmitter targets, but also revealed a novel
target of interest, the pregnane xenobiotic receptor (PXR; Frye
and Walf, 2008; Frye, 2009). The findings to date about this novel
target in the midbrain are described as follows.
BRIDGING SOURCES AND ACTIONS-ROLE OF PXR IN THE
MIDBRAIN VTA
PXR IS EXPRESSED IN THE BRAIN AND MAY HAVE
HORMONE-RELEVANT ACTIONS
A recent focus has been on characterizing the role of a promis-
cuous nuclear receptor, PXR, involved in cholesterol metabolism
and expressed in the VTA, as a target for allopregnanolone and
how this relates to both actions and production of allopreg-
nanolone. PXR has well-known metabolic and clearance actions
in the traditional organs for metabolism and excretion, such as the
liver, kidneys, intestines, and the blood-brain barrier (Geick et al.,
2001; Dussault and Forman, 2002; Kliewer et al., 2002; Francis
et al., 2003; Bauer et al., 2004, 2006; Xu et al., 2005; Harmsen
et al., 2007; Ma et al., 2008; Zhang et al., 2008; Ott et al., 2009).
It is considered a promiscuous nuclear receptor with a long list of
molecules that it positively modulates (including several steroids,
and allopregnanolone) and much fewer molecules that are nega-
tively modulated. Although early work on understanding the role
of PXR outside of the liver and other excretory organs in the
body was focused on the blood-brain-barrier, several laboratories,
including our own, have demonstrated its expression in the brain
proper (e.g., in rodents, rabbits, pigs, and humans; Bauer et al.,
2004; Lamba et al., 2004; Marini et al., 2007; Mellon et al., 2008;
Frye, 2011). In considering its role for metabolism and xenobiotic
(including steroid) clearance in the liver, we sought to determine
PXR’s functional effects related to allopregnanolone production
and/or action. PXR protein and mRNA was expressed in the
midbrain of proestrous rats, with higher expression (determined
by western blots) in female rats in proestrous versus those in die-
strous or male rats (Frye et al., 2012, 2013b), suggesting a possible
role of ovarian steroids (estradiol, progesterone) and/or pregnane
neurosteroids. These studies were correlational in nature and
demonstrated a relationship between hormonal milieu and sex
differences for expression of PXR.
MANIPULATIONS OF PXR IN THE MIDBRAIN FOR MATING
Next, studies investigated manipulations of PXR in the midbrain
for functional effects, including lordosis. Positive modulators
of PXR, such as allopregnanolone, other pregnane steroids
(3β,5α-THP, 3α,5β-THP), and RU486, when infused to the VTA,
enhanced lordosis of OVX, estradiol-primed rats (Frye, 2011).
However, these findings are tempered by the known promiscuity
of PXR. Follow-up studies utilized a pharmacogenetic tool (anti-
sense oligodeoxynucleotides, AS-ODNS) to reduce expression
of PXR in the midbrain VTA to further understand functional
outcomes (Frye, 2011; Frye et al., 2012, 2013a, 2014a,b). Investiga-
tions of the role of PXR, by using this PXR knockdown approach,
for mating-induced neurosteroidogenesis and functional effects
are ongoing, and some key findings are described as follows.
MANIPULATIONS OF PXR FOR ALLOPREGNANOLONE SYNTHESIS
The role of the PXR for biosynthesis of allopregnanolone in
the brain has been investigated. An approach that was utilized
to investigate this was to compare the capacity of rats with
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FIGURE 5 | Depicts the lordosis quotients of proestrous (PRO; positive
control) and ovariectomized (OVX) rats administered vehicle,
progesterone (P4) and/or allopregnanolone (AlloP) via subcutaneous
injections. Comparisons were made in Sprague-Dawley wildtype (WT) and
pregnane xenobiotic receptor (PXR) knockout (KO) rats on a Sprague-Dawley
background. This strain of rats is commercially available from SAGE Labs.
Data are represented as a percent of the WT proestrous control group. A
picture of lordosis is included above the data bars. PXRKO rats have lower
lordosis than do WT rats across hormone conditions, with similar
improvements in lordosis with replacement back of AlloP.
peripheral glands removed (e.g., the ovaries and/or the adrenal
glands) to produce allopregnanolone in the midbrain follow-
ing mating. In comparing rats that were OVX or OVX/ADX,
estradiol-primed and behaviorally tested in the paced mating task
to non-tested controls, there was a robust increase in midbrain
levels of allopregnanolone, particularly among the OVX rats,
with paced mating (Figure 1). This effect was attenuated when
rats were administered PXR AS-ODNs to the midbrain VTA
(Figure 1). Moreover, comparisons of rats that are paced mated
and in different hormonal states (proestrous, OVX, OVX/ADX)
and administered saline vehicle or PXR AS-ODN infusions to the
midbrain VTA corroborate these findings. Administration of PXR
AS-ODNs to the midbrain reduces allopregnanolone levels in
the midbrain following mating across these hormone conditions
(Figure 2). These data suggest a role of PXR for mating-induced
allopregnanolone secretion in the midbrain VTA.
PXR IS UPSTREAM OF TSPO FOR ALLOPREGNANOLONE SYNTHESIS
A question is how PXR may interact with other downstream
factors recognized to be involved in neurosteroidogenesis. Inves-
tigation of this question has begun by assessing the role of TSPO,
given that this is one rate-limiting factor for allopregnanolone
synthesis in the brain. Inhibiting TSPO with PK11195 reduced
allopregnanolone in the midbrain and lordosis, an effect that
could be reversed with allopregnanolone replacement, but not
when AS-ODNs and allopregnanolone were co-administered.
AS-ODNs blocked actions of FGIN 1-27 for lordosis and allo-
pregnanolone levels among proestrous > OVX > OVX/ADX
rats. Together, these data support the notion that PXR may
be upstream of TSPO. Investigations of the regulation of other
related factors are underway.
INTERACTIONS OF PXR, GLUTAMATE AND GABA RECEPTORS
Although these data suggest that PXR is important for the syn-
thesis of allopregnanolone in the midbrain, a related research
question is the downstream factors for allopregnanolone’s actions.
PXR AS-ODNs to the VTA, but not nearby midbrain sites, blocks
reproductive responding among receptive rats associated with
estrous cycle increases or following estradiol- and progestogen-
administration to OVX rats (Frye et al., 2012, 2013a, 2014a).
Moreover, knocking down expression of PXR in the midbrain
VTA attenuates actions of allopregnanolone via NMDA and/or
GABAA receptors for lordosis (Figure 3). That there were some
differences noted across hormonal milieu in this study, suggestive
of a role of allopregnanolone biosynthesis, follow-up questions
would include capacity for allopregnanolone biosynthesis in the
brain as well as responses to allopregnanolone administration
across these groups.
BEYOND SYNTHESIS AND ACTIONS OF
ALLOPREGNANOLONE IN THE MIDBRAIN VTA
MANIPULATIONS OF PXR ARE MOST SALIENT FOR
SOCIALLY-RELEVANT BEHAVIORS
Another area of interest is the role of PXR for other socially-
relevant behaviors. We have traditionally utilized studies such
as those described above to ascertain mechanisms of allopreg-
nanolone using lordosis in a mating task as one endpoint. Mat-
ing is typically assessed after other measures of behaviors that
may support reproduction (i.e., reproductively-relevant behav-
iors, such as exploration, anxiety, and pro-social behavior) that
allopregnanolone mediates (Frye, 2011; Frye et al., 2012, 2013a,b),
perhaps through its actions at GABAA receptors and NMDARs
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FIGURE 6 | Depicts the lordosis quotients of proestrous (PRO; positive
control) and ovariectomized (OVX) mice administered vehicle,
progesterone (P4) and/or allopregnanolone (AlloP) via subcutaneous
injections. Comparisons were made to C57BL/6Tac wildtype (WT) and
pregnane xenobiotic receptor (PXR) knockout (KO) mice on a C57BL/6Tac
background. This strain of mice is commercially available from Taconic. Data
are represented as a percent of the WT proestrous control group. A picture of
lordosis is included above the data bars. PXRKO mice have lower lordosis
than do WT mice across hormone conditions, except for with replacement
back of AlloP.
(Frye and Paris, 2009, 2011). In comparing the extent to which
PXR AS-ODNs reduce such behaviors, we have consistently noted
that the most robust effects are for lordosis quotients, followed by
other socially-relevant measures (aggression/rejection during the
mating task, and social investigation of a female conspecific), and
then affective measures (open arm exploration in the plus maze)
and then exploratory/ambulatory behavior (open field entries
made; Figure 4). These data suggest overall that manipulations of
PXR are most salient for socially-relevant behaviors, and that the
midbrain infusions of such drug manipulations are not associated
with non-specific effects of ambulatory behavior.
BRAIN TARGETS BEYOND THE MIDBRAIN VTA
These comparisons suggest the specificity of the response as well
as brain targets outside of the midbrain VTA. Among receptive
rats, mating-induced allopregnanolone synthesis is observed in
the midbrain as well as corticolimbic structures (hippocampus,
prefrontal cortex) and the hypothalamus (Frye et al., 2006a,
2007). PXR AS-ODNs to the midbrain VTA of receptive rats have
the most salient effects to reduce allopregnanolone in the mid-
brain, but reductions are also observed in the hippocampus (Frye
et al., 2013a, 2014a). Interestingly, PXR AS-ODNs to the mid-
brain VTA also reduce levels of the growth factor, brain-derived
neurotrophic factor (BDNF), in the hippocampus coincident with
differences in behavior (Frye et al., 2014b). Allopregnanolone has
actions on BDNF as well as cognitive performance of rodents
(Nin et al., 2011; Frye et al., 2013a; Bali and Jaggi, 2014). As
such, the extent to which PXR is a target of allopregnanolone
beyond the midbrain to corticolimbic structures is of great
interest. Indeed, genetic knockout of a related nuclear receptor
known for its actions in the liver, the liver X receptor, increases
anxiety-like behavior of mice and alters GABAergic function in
the hypothalamus, as well as may play a protective role in a
Parkinson’s disease mouse model (Dai et al., 2012; Tan et al.,
2012). Thus, we consider that allopregnanolone may have a role
via PXR in the midbrain and beyond for neural and behavioral
plasticity.
MATING BEHAVIOR OF PXR KNOCKOUT RATS AND MICE
We have begun characterizing the role of lifelong knock down
of PXR as well as species similarities/differences, using PXR
knockout (KO) rats and mice. Progesterone administration
produced similar rates of lordosis as observed among proe-
strous wildtype (WT), but not PXRKO, rats; both WT and
PXRKO rats responded to allopregnanolone administration with
increased lordosis (Figure 5). The same pattern was observed
among WT and PXRKO mice, suggesting species similarities in
this mechanism (Figure 6). These data corroborate what has
been observed with PXR knockdown in the VTA of rats to
reduce lordosis of receptive rats, but show that PXRKO rats
can respond to allopregnanolone administration (unlike what
has been observed with allopregnanolone infusions to the VTA
following PXR AS-ODN infusions; Frye et al., 2014a). These
results are promising in that they suggest a specific deficit in
synthesis of allopregnanolone, rather than binding of allopreg-
nanolone as just one of many, many positive modulators of
this promiscuous nuclear receptor. However, it is not known
what the capacity for mating-induced allopregnanolone, and
whether there are similar brain targets, is in these rodent mod-
els at this time. As well, a typical concern with models of
whole body and brain knockout of a gene throughout devel-
opment is the potential for compensatory mechanisms. Stud-
ies are ongoing to characterize these animal model resources
further.
Frontiers in Cellular Neuroscience www.frontiersin.org April 2014 | Volume 8 | Article 106 | 8
Frye et al. PXR: allopregnanolone production and action
FIGURE 7 | Model of proposed actions of allopregnanolone produced in
the brain via PXR and other novel targets, important for reproductive
responding. In summary, our lab has been focused on elucidating the novel
targets of allopregnanolone, such as PXR, for its functional effects. The data
to date suggest that PXR is a novel target of allopregnanolone in the midbrain
VTA, as are neurotransmitter targets (e.g., GABA, NMDA), for functional,
reproductively-relevant responses, as well as biosynthesis of
allopregnanolone in the brain (i.e., acting upstream of TSPO).
OTHER BEHAVIORAL PHENOTYPES IN THE PXR KNOCKOUT RATS AND
MICE—THE MIRROR MAZE
Of interest is whether there are other behavioral phenotypes in
the PXRKO rats and mice to consider. There are no apparent
differences in their homecage behavior, and systematic analyses
are underway to assess other behavioral endpoints. A prediction,
based upon the data with PXR AS-ODNs, is that the most salient
effects of PXR knockout may be for reproductive measures (as
supported by data in Figures 5 and 6) or social behaviors. Indeed,
a pilot assessment of WT and PXRKO mice in the mirror maze
supports this notion. The mirror maze is a behavioral assessment
of acute changes in rodents’ responses to observations of their
own image in a mirror (Houri, 1986; Lamberty, 1998). This
task, like several others considered to be an index of affective
responsing (e.g., elevated plus maze), is considered a free-choice
conflict task in which the time spent by the rodent in the mirrored
section of a cubed chamber is compared to the time spent away
from the mirrors in an adjoined alleyway without mirrors
(Henderson et al., 2004; Frye et al., 2006b). We have utilized
this task to assess the role of allopregnanolone and other steroid
targets, including the androstane equivalent of allopregnanolone
(3α-androstanediol; Frye et al., 2006b, 2008; Walf et al., 2009).
In initial assessments of female WT and PXRKO mice during the
proestrus phase of the estrous cycle, we noted an approximately
15% increase in time spent in the mirror chamber among the
PXRKO mice (197 s) than in the WT mice (172 s). This pattern
is opposite to what has been noted with PXR knockdown or
knockout for interaction with a mate or conspecific (as described
above). As well, female mice with knockout of estrogen receptor
beta, which may be another important factor in allopregnanolone
synthesis, but not progestin receptor, respond poorly in this task.
These data in the mirror maze are interesting as they suggest a
role of PXR for mediating responses to another socially-relevant
stimuli, the rodents’ own image in a mirror, beyond a mate (as in
the paced mating task) or another female conspecific (as in the
social interaction task). Although a focus has been on actions of
allopregnanolone in the midbrain VTA, how the understanding
of these novel targets in this region can be extended elsewhere in
the CNS relevant for clinical conditions is of continued interest.
BEYOND HOMEOSTASIS—ALLOPREGNANOLONE’S ROLE IN
TRANSLATION
Diverse functions have been ascribed to the actions of
allopregnanolone, including many of the actions described above
for reproduction and other reproductively-relevant behaviors.
Our understanding of allopregnanolone’s actions in the VTA for
lordosis has been extended to reveal the role of allopregnanolone
for broader, clinically-relevant questions, such as neurodevel-
opmental processes, neuropsychiatric disorders, epilepsy, and
aging (reviewed in Frye, 2009). Some examples about the role
of allopregnanolone for seizure and affective processes in clinical
populations are as follows. Large clinical trials and a case study
support that allopregnanolone may be involved in seizure control
(Herzog and Frye, 2003; Herzog et al., 2006, 2014). There are
mediating effects of allopregnanolone for anxiety and depressive
symptoms among women with premenstrual dysphoric disorder
(Endicott et al., 1999; Freeman et al., 2002; Gracia et al., 2009)
as well as self-reported anxiety in men with post-traumatic
stress disorder following exposure to trauma cue (Casada et al.,
1998; Frye, 2009). Furthermore, allopregnanolone may underlie
some of the effects of therapeutics. Fluoxetine can enhance
dihydroprogesterone (DHP)’s affinity for 3α-HSD, thereby
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increasing allopregnanolone formation (Griffin and Mellon,
1999). Reductions in depressive symptoms of men or women
diagnosed with major depression are correlated with higher
cerebrospinal fluid levels of allopregnanolone (Romeo et al.,
1998; Uzunova et al., 1998). Thus, biosynthesis and subsequent
rapid effects of allopregnanolone at its non-traditional targets
(GABAA, glutamate, dopamine, and PXR) are mechanisms of
continued interest with respect to these clinical conditions.
SUMMARY AND CONCLUSIONS
In summary, investigations of allopregnanolone’s production
and function in the midbrain VTA have focused on mating
as a measure and manipulation of allopregnanolone. First,
there are traditional (metabolism from peripheral steroids) and
nontraditional (biosynthesis, or production in the brain from
cholesterol, following challenges such as mating) means for
production of allopregnanolone in the central nervous system.
Second, the non-traditional mechanisms in the brain that
allopregnanolone has for behavioral processes, including mating
and reproduction-relevant behaviors, depends upon rapid
modulation of neurotransmitters (GABA, glutamate, dopamine),
instead of binding to steroid receptors. Third, PXR is a target
bridging the synthesis of allopregnanolone with its functions
in brain and may be upstream of TSPO and modulate actions
of allopregnanolone via neurotransmitter targets (Figure 7).
Fourth, the significance of studying the functions and mechanism
of allopregnanolone in VTA can be extended to clinically-
relevant findings for neuropsychiatric, neurodevelopmental,
neurodegenerative, and/or age-related disorders. In conclusion,
neurosteroids have novel actions, which are now well-accepted,
related to their production in the brain and their actions through
non-steroid receptor targets. Future considerations include
further understanding another characteristic of neurosteroids,
which their capacity to induce steroidogenic enzymes in the
brain, and thus be involved in clearance (as is PXR). As such,
the role of PXR as a factor involved in steroid production,
action, and clearance in the brain is of continued study in our
laboratory.
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